ArticleCureus2026
Prevention of Lower Limb Muscle Atrophy With Neuromuscular Electrical Stimulation in a Patient With Tachycardia-Induced Cardiomyopathy Secondary to Thyroid Storm: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tachycardia-induced cardiomyopathy (TIC) is reversible; however, the acute phase is often accompanied by hemodynamic instability, which makes conventional exercise therapy difficult to implement. Neuromuscular electrical stimulation (NMES) has been suggested as a potential alternative strategy to prevent muscle atrophy. Herein, we report a case in which NMES was used in a patient during the acute phase of TIC, secondary to thyroid storm, highlighting its safety and potential effectiveness. A male in his 40s was diagnosed with TIC associated with thyroid storm. On admission, the patient presented with atrial fibrillation, severe cardiac dysfunction with a left ventricular ejection fraction of 19%, and markedly elevated thyroid hormone levels. Due to unstable hemodynamics, conventional exercise therapy was deferred, and NMES was initiated on day nine of hospitalization, and it was continued until day 12. It was performed once daily for 20 minutes. Muscle ultrasonography revealed that quadriceps muscle thickness had decreased by approximately 5% during hospitalization. Importantly, no hemodynamic deterioration or adverse events were observed. From day 13, aerobic exercises using a cycle ergometer and resistance training were initiated. The patient achieved a six-minute walk distance of 545 m and was discharged on day 28. NMES was safely implemented without adverse events, even during periods of hemodynamic instability in a patient with TIC. In situations where conventional exercise therapy is limited due to hemodynamic instability, NMES may represent a feasible intervention option. The findings of this single case are hypothesis-generating and warrant further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.